RSNA 2014 Editor’s Choice of the Most Innovative New Technology | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Illumina launches three new Sequencing Systems and New Diagnostic Plans: Noninvasive Prenatal Testing and Oncology Markets

Myriad Genetics: On Day One of JP Morgan Healthcare Conference, San Francisco, January 12, 2015 – January 15, 2015 »

RSNA 2014 Editor’s Choice of the Most Innovative New Technology

January 13, 2015 by 2012pharmaceutical

RSNA 2014 Editor’s Choice of the Most Innovative New Technology

Reporter: Aviva Lev-Ari, PhD, RN

Here are ITN Editor Dave Fornell’s choices for the most innovative new imaging technologies shown on the expo floor at the Radiological Society of North America (RSNA) 2014 annual meeting.

VIEW VIDEO

http://www.itnonline.com/view-all/videos?bclid=910141019001&bctid=3938820152001

Posted in CT, FDA Regulatory Affairs, Medical Devices R&D Investment, Medical Imaging Technology, Medical Imaging Technology, Image Processing/Computing, MRI, CT, Nuclear Medicine, Ultra Sound | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- Press Release for Five Bilingual BioMed e-Series January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: